Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 24, 2017
Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe formsPaul Coppo,
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2019
Types of fresh plasma with focus on therapeutic plasma exchangeOlivier Garraud, Paul Coppo
Nephrologie & Therapeutique|June 5, 2017
Thrombotic microangiopathies and antineoplastic agentsSteven Grangé, Paul Coppo,
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 26, 2019
When targeted therapies alleviate the burden of TPE: The example of immune-mediated TTPAdrien Picod, Paul Coppo
Presse Medicale (Paris, France : 1983)|January 24, 2012
Current management and therapeutical perspectives in thrombotic thrombocytopenic purpuraPaul Coppo, Agnès Veyradier
Biodiversity Data Journal|November 11, 2021
A new species of <i>Cheironitis</i> van Lansberge, 1875 from Jordan (Coleoptera, Scarabaeidae, Onitini)Paul Coppo, Olivier Montreuil
Cardiovascular & Hematological Disorders Drug Targets|March 12, 2009
Thrombotic microangiopathies: towards a pathophysiology-based classificationPaul Coppo, Agnès Veyradier
Expert Review of Hematology|May 17, 2019
Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpuraAdrien Picod, Paul Coppo
Medecine Sciences : M/S|December 24, 2011
[ADAMTS13, von Willebrand factor specific cleaving protease]Agnès Veyradier, Paul Coppo
Hematology. American Society of Hematology. Education Program|December 6, 2015
Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchangePaul Coppo, Antoine Froissart,
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 24, 2017
Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe formsPaul Coppo,
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2019
Types of fresh plasma with focus on therapeutic plasma exchangeOlivier Garraud, Paul Coppo
Nephrologie & Therapeutique|June 5, 2017
Thrombotic microangiopathies and antineoplastic agentsSteven Grangé, Paul Coppo,
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 26, 2019
When targeted therapies alleviate the burden of TPE: The example of immune-mediated TTPAdrien Picod, Paul Coppo
Presse Medicale (Paris, France : 1983)|January 24, 2012
Current management and therapeutical perspectives in thrombotic thrombocytopenic purpuraPaul Coppo, Agnès Veyradier
Biodiversity Data Journal|November 11, 2021
A new species of <i>Cheironitis</i> van Lansberge, 1875 from Jordan (Coleoptera, Scarabaeidae, Onitini)Paul Coppo, Olivier Montreuil
Cardiovascular & Hematological Disorders Drug Targets|March 12, 2009
Thrombotic microangiopathies: towards a pathophysiology-based classificationPaul Coppo, Agnès Veyradier
Expert Review of Hematology|May 17, 2019
Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpuraAdrien Picod, Paul Coppo
Medecine Sciences : M/S|December 24, 2011
[ADAMTS13, von Willebrand factor specific cleaving protease]Agnès Veyradier, Paul Coppo
Hematology. American Society of Hematology. Education Program|December 6, 2015
Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchangePaul Coppo, Antoine Froissart,
Pageof 20